Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease. Here, HDAC2 is linked to early-onset autosomal dominant Alzheimer disease.